METHYLONE PRODUCES ANTIDEPRESSANT-RELEVANT ACTIONS AND PROSOCIAL EFFECTS
Abstract Background Methylone (3,4-methylenedioxy-N-methylcathinone) is a rapid-acting entactogen that has been shown to have significant benefits in patients with post-traumatic stress disorder and major depressive disorder and is well tolerated in phase 1 clinical trials. A recent preclinical study reported that methylone produced robust antidepressant-like actions in naï ve rats. However, its antidepressant effects on various stress-related psychopathologies and other neuropsychological actions remain unclear. Aims & Objectives In the present study, we examined the antidepressant-relevant effects of methylone in learned helplessness (LH) and social defeat stress C57BL/6J male mouse models and further explored its sociability-relevant neuropsychological actions. Methods Tail suspension test, female urine sniffing test, sucrose preference test, social interaction test, three-chamber test, social behavior test, observed fear conditioning, helping behavior, and electrophysiological recording were used. Results Our results indicate that methylone produces antidepressant-relevant effects on the helpless phenotype, LH-evoked depressive-like behaviors, and psychosocial stress-induced social avoidance, and induced depressive-like behaviors. In addition, methylone was found to enhance social preference and increase various social behaviors, including social contact, sniffing, allogrooming, and following. Moreover, methylone appeared to elevate empathy-like phenotypes and was also found to increase helping-like behavior. Discussion & Conclusion Overall, the present results suggest that methylone plays an antidepressant-like role in various stress-relevant psychopathologies and could be an ideal antidepressant candidate. In addition, novel findings on the elevated tendencies of social preference and empathy-like and helping-like phenotypes reveal that methylone may have potential application in patients with social deficits.
Authors
- Hsien‐Yu Peng (ORCID: https://orcid.org/0000-0002-9471-8130)
- Cheng‐Yuan Lai (ORCID: https://orcid.org/0000-0002-5732-9814)
- Hsi‐Tien Wu (ORCID: https://orcid.org/0000-0001-8527-9597)
- Ming‐Chun Hsieh
- Lih‐Chyang Chen
- Zhenlong Li (ORCID: https://orcid.org/0000-0002-8938-5466)
- Dylan Chou (ORCID: https://orcid.org/0000-0001-8783-8495)
- Mei-Ci Chen
- Chau‐Shoun Lee (ORCID: https://orcid.org/0000-0002-1509-4340)
- Tzer-Bin Lin
Institutions
- Zunyi Medical University (CN)
- Mackay Memorial Hospital (TW)
- Mackay Medical University (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- The International Journal of Neuropsychopharmacology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1093/ijnp/pyae059.359
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00